KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Restructuring Costs (2016 - 2026)

Globus Medical filings provide 11 years of Restructuring Costs readings, the most recent being $10.8 million for Q4 2025.

  • On a quarterly basis, Restructuring Costs fell 36.65% to $10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.3 million, a 42.88% increase, with the full-year FY2025 number at $42.3 million, up 42.88% from a year prior.
  • Restructuring Costs hit $10.8 million in Q4 2025 for Globus Medical, up from -$2.7 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $33.2 million in Q2 2025 to a low of -$8.6 million in Q4 2021.
  • Median Restructuring Costs over the past 5 years was $1.9 million (2022), compared with a mean of $5.0 million.
  • The widest YoY moves for Restructuring Costs: up 24667.86% in 2021, down 362.11% in 2021.
  • Globus Medical's Restructuring Costs stood at -$8.6 million in 2021, then soared by 148.6% to $4.2 million in 2022, then skyrocketed by 273.38% to $15.6 million in 2023, then rose by 9.67% to $17.1 million in 2024, then crashed by 36.65% to $10.8 million in 2025.
  • The last three reported values for Restructuring Costs were $10.8 million (Q4 2025), -$2.7 million (Q3 2025), and $33.2 million (Q2 2025) per Business Quant data.